FDA commissioner Dr. Marty Makary joins "CBS Mornings" to discuss the agency's announcement Thursday that boxed warnings will be removed from many estrogen products used for hormone therapy, a treatment that helps alleviate the symptoms of menopause.
Breakdown
- The FDA will remove black box warnings from many menopause hormone therapies, potentially benefiting tens of millions of women. 22s
- Black box warnings have been on estrogen-containing menopause treatments since 2003, warning of increased risks of breast cancer, stroke, and dementia. 31s
- FDA Commissioner Dr. Marty McCary says new data show these treatments are safe and provide many health benefits, including improved quality of life. 46s
- A government study over 20 years ago led to a decline in hormone therapy use, but recent evidence does not show increased breast cancer mortality. 3m 7s
- The FDA expects that removing the warning labels will make it easier for women and doctors to discuss hormone therapy as a treatment option. 5m 17s